- The most respected evidence-based reports available to medical professionals that highlight new advances in the medical field.
- Research has been published in 25 medical journals over the past decade proving the effectiveness of the EMPowerplus Q96™ formulation.
- Including a newly released double blind study, which is the Gold Standard of medical research. For details of this specific study please CLICK HERE
- The founders have been approached by 41 independent researchers over the last decade who have contributed to ongoing studies.
- The research that has resulted has been positive and has shown significant improvement in the lives of those with mood disorders.
- The EMPowerplus Q96™ formulation has been studied around the world including at 15 renowned universities.
- Since the reach of the EMPowerplus Q96™ research has been phenomenal, it has spread throughout the world and has taken place across North America, Europe, New Zealand, and Australia
Empowerplus Q96 RESEARCH #1 : EFFICACY AND COST OF MICRONUTRIENT TREATMENT OF CHILDHOOD PSYCHOSIS
EMPowerplus Q96 RESEARCH #2: FEASABILITY OF A NUTRITIONAL SUPPLEMENT AS TREATMENT FOR PEDIATRIC BIPOLAR SPECTRUM DISORDERS
EMPOwerplus Q96 RESEARCH #3: EFFECTS OF MICRONUTRIENTS ON STRESS AND TRAUMA AFTER AN EARTHQUAKE
Q96 RESEARCH #4: POST-EARTHQUAKE PSYCHOLOGICAL FUNCTIONING IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
EMPowerplus Q96 RESEARCH #5: MICRONUTRIENTS REDUCE STRESS AND ANXIETY IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER FOLLOWING A 7.1 EARTHQUAKE
EMPowerplus Q96 RESEARCH #6: CAN MICRONUTRIENTS IMPROVE NEUROCOGNITIVE FUNCTIONING IN ADULTS WITH ADHD AND SEVERE MOOD DYSREGULATION? A PILOT STUDY.
Q96 RESEARCH #7: SYSTEMATIC REVIEW OF SAFETY AND TOLERABILITY OF A COMPLEX MICRONUTRIENT FORMULA USED IN MENTAL HEALTH
EMpowerplus Q96 RESEARCH #8: EFFECT OF MICRONUTRIENTS ON BEHAVIOR AND MOOD IN ADULTS WITH ADHD
EMPowerplus Q96 RESEARCH #9: DATABASE ANALYSIS OF CHILDREN AND ADOLESCENTS WITH BIPOLAR DISORDER CONSUMING A MICRONUTRIENT FORMULA
EMPowerplus Q96 RESEARCH #10: SUCCESSFUL TREATMENT OF BIPOLAR DISORDER II AND ADHD WITH A MICRONUTRIENT FORMULA: A CASE STUDY
EMpowerplus Q96 RESEARCH #12: DATABASE ANALYSIS OF ADULTS WITH BIPOLAR DISORDER CONSUMING A MICRONUTRIENT FORMULA
EMPowerplus Q96 RESEARCH #13: SUCCESSFUL TREATMENT OF OCD WITH A MICRONUTRIENT FORMULA FOLLOWING PARTIAL RESPONSE TO COGNITIVE BEHAVIORAL THERAPY (CBT): A CASE STUDY
EMpowerplus Q96 RESEARCH #14: MULTINUTRIENT SUPPLEMENT AS TREATMENT: LITERATURE REVIEW AND CASE REPORT OF A 12-YEAR-OLD BOY WITH BIPOLAR DISORDER
EMPowerplus Q96 RESEARCH #15: IMPROVED MOOD AND BEHAVIOR DURING TREATMENT WITH A MINERAL-VITAMIN SUPPLEMENT: AN OPEN-LABEL CASE SERIES OF CHILDREN
EMpowerplus Q96 RESEARCH #16: DIET CAN STIMULATE FUNCTIONAL RECOVERY AND CEREBRAL PLASTICITY AFTER PERINATAL CORTICAL INJURY IN RATS
Empowerplus Q96 RESEARCH #18: NUTRITIONAL APPROACH TO BIPOLAR DISORDER
Empowerplus Q96 RESEARCH #19: DO VITAMINS OR MINERALS HAVE MOOD-STABILIZING EFFECTS?
Empowerplus Q96 RESEARCH #21: USE OF MICRONUTRIENTS ATTENUATES CANNABIS AND NICOTINE ABUSE AS EVIDENCED FROM A REVERSAL DESIGN
Empowerplus Q96 RESEARCH #22: COULD YEAST INFECTIONS IMPAIR RECOVERY FROM MENTAL ILLNESS?
EMPOWERPLUS Q96 RESEARCH #23: Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial
ABSTRACTS OF PUBLISHED EMPIRICAL REPORTS
This case adds to a growing body of research supporting the use of micronutrients in the treatment of psychiatric symptoms and suggests it may extend to substance dependence. Micronutrients, by assisting with mood regulation and reductions in anxiety, may assist with successful cessation of drug use. Alternatively, they may directly impact on the brain reward circuitry believed to be involved in the expression of addictions, thereby providing the appropriate precursors and cofactors necessary for adequate neurotransmitter synthesis. This case should continue to stimulate researchers to consider the role of nutrients, in particular vitamins and minerals, in drug treatment programs and encourage more rigorous trials. 22.Could yeast infections impair recovery from mental illness? A case study using micronutrients and olive leaf extract for the treatment of ADHD and depression Rucklidge JJ Advances in Mind-Body Medicine Journal, Summer 2013 – Vol 27, No. 3 ABSTRACT:Micronutrients are increasingly used to treat psychiatric disorders including attention-deficit/hyperactivity disorder (ADHD), mood disorders, stress, and anxiety. However, a number of factors influence optimal response and absorption of nutrients, including the health of the gut, particularly the presence of yeast infections, such as Candida. As part of a wider investigation into the impact of micronutrients on psychiatric symptoms, many participants who experienced a yeast infection during their treatment showed a diminished response to the micronutrients. One case was followed systematically over a period of 3 y with documentation of deterioration in psychiatric symptoms (ADHD and mood) when infected with Candida and then symptom improvement following successful treatment of the infection with olive leaf extract (OLE) and probiotics. This case outlines that micronutrient treatment might be severely compromised by infections such as Candida and may highlight the importance of gut health when treating psychiatric disorders with nutrients. Given the role that inflammation can play in absorption of nutrients, it was hypothesized that the infection was impairing absorption of the micronutrients. 25.Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial Julia J. Rucklidge, Chris M. Frampton, Brigette Gorman and Anna Boggis The British Journal of Psychiatry, Published online ahead of print January 30, 2014, doi: 10.1192/bjp.bp.113.132126
AIMS: To investigate the efficacy and safety of a broad-based micronutrient formula consisting mainly of vitamins and minerals, without omega fatty acids, in the treatment of ADHD in adults.
METHOD: Intent-to-treat analyses showed significant between-group differences favouring active treatment on self- and observer- but not clinician-ADHD rating scales. However, clinicians rated those receiving micronutrients as more improved than those on placebo both globally and on ADHD symptoms. Post hoc analyses showed that for those with moderate/severe depression at baseline, there was a greater change in mood favouring active treatment over placebo. There were no group differences in adverse events.
CONCLUSIONS: This study provides preliminary evidence of efficacy for micronutrients in the treatment of ADHD symptoms in adults, with a reassuring safety profile.